Skip to content
Application 761083
- Type
- BLA
- Sponsor
- GENENTECH INC
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | HEMLIBRA | EMICIZUMAB | INJECTABLE;INJECTION | 30MG/ML | Yes | No |
| 002 | HEMLIBRA | EMICIZUMAB | INJECTABLE;INJECTION | 60MG/0.4ML | Yes | No |
| 003 | HEMLIBRA | EMICIZUMAB | INJECTABLE;INJECTION | 105MG/0.7ML | Yes | No |
| 004 | HEMLIBRA | EMICIZUMAB | INJECTABLE;INJECTION | 150MG | Yes | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 50242-920 | Hemlibra | emicizumab | Genentech, Inc. | BLA | Current |
| 50242-920 | Hemlibra | emicizumab | Genentech, Inc. | BLA | Current |
| 50242-920 | Hemlibra | emicizumab | Genentech, Inc. | BLA | Current |
| 50242-920 | Hemlibra | emicizumab | Genentech, Inc. | BLA | Current |
| 50242-920 | Hemlibra | emicizumab | Genentech, Inc. | BLA | Current |
| 50242-920 | Hemlibra | emicizumab | Genentech, Inc. | BLA | Current |
| 50242-920 | Hemlibra | emicizumab | Genentech, Inc. | BLA | Current |
| 50242-921 | Hemlibra | emicizumab | Genentech, Inc. | BLA | Current |
| 50242-921 | Hemlibra | emicizumab | Genentech, Inc. | BLA | Current |
| 50242-921 | Hemlibra | emicizumab | Genentech, Inc. | BLA | Current |
| 50242-921 | Hemlibra | emicizumab | Genentech, Inc. | BLA | Current |
| 50242-921 | Hemlibra | emicizumab | Genentech, Inc. | BLA | Current |
| 50242-921 | Hemlibra | emicizumab | Genentech, Inc. | BLA | Current |
| 50242-921 | Hemlibra | emicizumab | Genentech, Inc. | BLA | Current |
| 50242-922 | Hemlibra | emicizumab | Genentech, Inc. | BLA | Current |
| 50242-922 | Hemlibra | emicizumab | Genentech, Inc. | BLA | Current |
| 50242-922 | Hemlibra | emicizumab | Genentech, Inc. | BLA | Current |
| 50242-922 | Hemlibra | emicizumab | Genentech, Inc. | BLA | Current |
| 50242-922 | Hemlibra | emicizumab | Genentech, Inc. | BLA | Current |
| 50242-922 | Hemlibra | emicizumab | Genentech, Inc. | BLA | Current |
| 50242-922 | Hemlibra | emicizumab | Genentech, Inc. | BLA | Current |
| 50242-923 | Hemlibra | emicizumab | Genentech, Inc. | BLA | Current |
| 50242-923 | Hemlibra | emicizumab | Genentech, Inc. | BLA | Current |
| 50242-923 | Hemlibra | emicizumab | Genentech, Inc. | BLA | Current |
| 50242-923 | Hemlibra | emicizumab | Genentech, Inc. | BLA | Current |
| 50242-923 | Hemlibra | emicizumab | Genentech, Inc. | BLA | Current |
| 50242-923 | Hemlibra | emicizumab | Genentech, Inc. | BLA | Current |
| 50242-923 | Hemlibra | emicizumab | Genentech, Inc. | BLA | Current |